The global endovascular aneurysm repair (EVAR) market size reached US$ 3.0 Billion in 2023. Looking forward, the market is projected to reach US$ 4.3 Billion by 2032, exhibiting a growth rate (CAGR) of 4.08% during 2023-2032.
An aneurysm refers to the enlargement of the arterial wall due to weakness or degeneration. It is generally associated with tobacco consumption and smoking. The prevalence of aneurysms is also higher among people with medical conditions such as atherosclerosis, high cholesterol levels, and connective tissue disorder. Endovascular aneurysm repair (EVAR) refers to a minimally invasive procedure or surgery that is performed to repair these aneurysms. EVAR procedure is performed by inserting a covered stent, a metal mesh tube with a layer of fabric, into the weak area of the artery. This provides a route for the blood to flow without accumulating in the bulge and prevents it from bursting. Nowadays, multiple devices are available in the market that are used to treat aneurysms.
The EVAR treatment is comparatively safer than traditional procedures, as there is no need for performing surgery. As a result, this technique results in short hospital stays and quicker recovery. Due to the prevalence of aneurysms, along with the growing geriatric population, endovascular treatment is increasingly being adopted by healthcare providers. This has further been supported by the rising awareness of the potential benefits of the procedure. Also, governments across the globe are undertaking several programs to improve the cost structure and spread awareness about the availability of EVAR devices and treatment procedures among patients.
In line with this, healthcare institutions are developing EVAR devices and technologies that offer faster recovery and fewer complications. For instance, enhanced graft technologies have been created, which allow treatments with short landing zones and improve conformability to the artery curvature. These technologies have further helped in increasing the success rate of EVAR procedures.
An aneurysm refers to the enlargement of the arterial wall due to weakness or degeneration. It is generally associated with tobacco consumption and smoking. The prevalence of aneurysms is also higher among people with medical conditions such as atherosclerosis, high cholesterol levels, and connective tissue disorder. Endovascular aneurysm repair (EVAR) refers to a minimally invasive procedure or surgery that is performed to repair these aneurysms. EVAR procedure is performed by inserting a covered stent, a metal mesh tube with a layer of fabric, into the weak area of the artery. This provides a route for the blood to flow without accumulating in the bulge and prevents it from bursting. Nowadays, multiple devices are available in the market that are used to treat aneurysms.
The EVAR treatment is comparatively safer than traditional procedures, as there is no need for performing surgery. As a result, this technique results in short hospital stays and quicker recovery. Due to the prevalence of aneurysms, along with the growing geriatric population, endovascular treatment is increasingly being adopted by healthcare providers. This has further been supported by the rising awareness of the potential benefits of the procedure. Also, governments across the globe are undertaking several programs to improve the cost structure and spread awareness about the availability of EVAR devices and treatment procedures among patients.
In line with this, healthcare institutions are developing EVAR devices and technologies that offer faster recovery and fewer complications. For instance, enhanced graft technologies have been created, which allow treatments with short landing zones and improve conformability to the artery curvature. These technologies have further helped in increasing the success rate of EVAR procedures.
Key Market Segmentation
This report provides an analysis of the key trends in each sub-segment of the global endovascular aneurysm repair (EVAR) market report, along with forecasts at the global and regional level from 2024-2032. The report has categorized the market based on indication, product, gender, age and end-user.Breakup by Indication:
- Abdominal Aortic Aneurysm (AAA)
- Thoracic Aortic Aneurysm (TAA)
- Thoracoabdominal Aortic Aneurysm (TAAA)
- Others
Breakup by Product:
- Percutaneous EVAR
- Fenestrated EVAR
- Aortic Stents and TAA Grafts
- Others
Breakup by Gender:
- Male
- Female
- Pediatric
- Adult
- Geriatric
Breakup by End-User:
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Others
Breakup by Region:
- Asia Pacific
- Europe
- North America
- Middle East and Africa
- Latin America
Competitive Landscape
The report has also analyzed the competitive landscape of the market with some of the key players being Medtronic plc, Cook Group Incorporated, W. L. Gore & Associates, Inc., Bolton Medical, Inc., Gamida Cell Ltd., JOTEC GmbH, Getinge AB (Maquet), Shanghai MicroPort Medical (Group) Co., Ltd., Terumo Corporation, Endologix, Inc., Lombard Medical Limited, and Cardinal Health, Inc.Key Questions Answered in This Report
- How has the global endovascular aneurysm repair market performed so far and how will it perform in the coming years?
- What are the key regional markets in the industry?
- What has been the impact of COVID-19 on the global endovascular aneurysm repair industry?
- What is the breakup of the market based on the indication?
- What is the breakup of the market based on the product?
- What is the breakup of the market based on the gender?
- What is the breakup of the market based on the age?
- What is the breakup of the market based on the end-user?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the industry and who are the key players?
- What is the degree of competition in the industry?
Table of Contents
1 Preface3 Executive Summary13 Value Chain Analysis15 Price Analysis
2 Scope and Methodology
4 Introduction
5 Global Endovascular Aneurysm Repair Market
6 Market Breakup by Indication
7 Market Breakup by Product
8 Market Breakup by Gender
9 Market Breakup by Age
10 Market Breakup by End-User
11 Market Breakup by Region
12 SWOT Analysis
14 Porter’s Five Forces Analysis
16 Competitive Landscape
List of Figures
List of Tables
Companies Mentioned
- Medtronic plc
- Cook Group Incorporated
- W. L. Gore & Associates Inc.
- Bolton Medical Inc.
- Gamida Cell Ltd.
- JOTEC GmbH
- Getinge AB (Maquet)
- Shanghai MicroPort Medical (Group) Co. Ltd.
- Terumo Corporation
- Endologix Inc.
- Lombard Medical Limited
- Cardinal Health Inc.
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 135 |
| Published | April 2024 |
| Forecast Period | 2023 - 2032 |
| Estimated Market Value ( USD | $ 3 Billion |
| Forecasted Market Value ( USD | $ 4.3 Billion |
| Compound Annual Growth Rate | 4.0% |
| Regions Covered | Global |
| No. of Companies Mentioned | 12 |
